Follow Us On Social Media

 
 
NeurologyWire
 

Investigational BACE Inhibitor for Early Alzheimer’s Disease Moves to Phase 3 Trials

An investigational BACE inhibitor for the treatment of early Alzheimer’s disease is moving into Phase 3 trials, following confirmation from the FDA. Developed in a partn… read more

Once-Monthly Self-Administered Multiple Sclerosis Treatment Zinbryta Wins FDA Approval

The FDA has approved Zinbryta (daclizumab, Biogen/AbbVie), a once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis (RMS). The … read more

NFL Player Donates to Studies Investigating Cannabinoids for Pain and CTE

NFL player Eugene Monroe has donated $80,000 to researchers at Johns Hopkins University and the University of Pennsylvania to examine the therapeutic potential of cannabinoid … read more

New Drug Class Established as Nuplazid Receives FDA Approval for Parkinson’s Disease Psychosis

The FDA has approved Nuplazid (pimavanserin) from Acadia Pharmaceuticals for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis, whi… read more

AAN Unveils Overhauled Botulinum Toxin Guidelines

The American Academy of Neurology (AAN) has adopted new guidelines for the use of botulinum toxins for blepharospasm, cervical dystonia (CD), headache, and adult spasticity. T… read more

Featured NeuroTopic

 

Stroke/Cerebrovascular

physician counsel

Curated by Bryn Mawr Communications II and Endovascular Today

Registry Assessment of Peripheral Interventional Devices (RAPID)

Developing a minimum core dataset for total product life cycle device evaluation across multiple data sources: a step toward establishing a National Evaluation System for Health Technology for peripheral intervention devices.

The Benefits of Office-Based Labs

A panel shares insights into using office-based labs to plan for the future.

A Field Guide to Radiation Safety Terminology

An overview of key radiation dosimetric quantities and terms.

 
 

Contact Info

For advertising rates and opportunities:
Steve Farrell
Publisher
973-768-8681
sfarrell@bmctoday.com

For further information:
Alan Guralnick
Group Publisher
(484) 581-1832
aguralnick@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC